Protopic for maintenance therapy

The licensed indications for Protopic (tacrolimus) ointment have been extended to include maintenance therapy of moderate to severe atopic dermatitis for the prevention of flares and prolongation of flare-free intervals.

Maintenance treatment is suitable for patients experiencing a high frequency of disease exacerbations (occurring four or more times a year) who have had an initial response to a maximum of six weeks treatment of twice daily application of tacrolimus ointment. An initial response is defined as lesions cleared, almost cleared or mildly affected.

For maintenance the ointment should be applied once a day twice weekly with a gap of two to three days between applications. At the first signs of a recurrence (flare) of disease symptoms the treatment dose should be resumed. Maintenance therapy should be reviewed after 12 months.

View Protopic drug record

Further information: Astellas Pharma

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk

SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk

Cases of necrotising fasciitis of the genitalia or...

New advice for carbimazole over malformation and pancreatitis risks

New advice for carbimazole over malformation and pancreatitis risks

Reports of congenital malformations and acute pancreatitis...

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Potential sensitising agents in eye drops and ointments.

Antibiotic Treatments in Adults, Summary of Regimens

Antibiotic Treatments in Adults, Summary of Regimens

Dose regimens for common bacterial infections.